Left Atrial Appendage (LAA) Occluders

LAA occluder, Watchman

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman ...

Lariat Procedure Reduces Stroke Risk in Patients Who Cannot Tolerate Blood Thinn

Shore University Medical Center is one of only a handful of hospitals in the country offering the recent U.S. Food and Drug Administration (FDA)-approved Lariat Suture Delivery Device procedure. Electrophysiologists and interventional cardiologist...

July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system devices worldwide.
atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
The TigerPaw System II is a mechanical occlusion device developed by LAAx Inc. When implanted, TigerPaw II safely and effectively occludes
The Simbionix Angio Mentor is a virtual reality-training simulator, providing hands-on practice in a simulated environment for endovascular...
A device for excluding the left atrial appendage has received clearance from the FDA. AtriCure, Inc. has received clearance from the U.S....

Articles

atrial fibrillation, LARIAT
Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat...
Watchman, LAA occluder, atrial fibrillation
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in...
LAA occluder, Watchman
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
4 weeks 5 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
6 weeks 6 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
7 weeks 6 days ago
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live...